相关实验视频
Updated: Jun 15, 2025

08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
7.5K
重新编程与乳腺瘤相关的巨细胞,调节阿金代谢
Veani Fernando1,2, Xunzhen Zheng1, Vandana Sharma1,3
1Department of Cell & Cancer Biology, College of Medicine and Life Sciences, University of Toledo Health Science Campus, Toledo, OH, USA.
Life science alliance
|August 27, 2024
概括
塞帕特林 (SEP) 可以在HER2+乳腺瘤中将免疫抑制的M2瘤相关巨细胞 (TAMs) 重编为M1TAMs. 这种代谢转变增强了抗瘤免疫力,并提供了一种新的免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 代谢途径 代谢途径
背景情况:
- HER2+乳腺瘤的特点是丰富的免疫抑制M2瘤相关巨细胞 (TAMs).
- 降低M1/M2-TAM比率有助于瘤免疫逃避和免疫治疗抵抗.
- 不同的阿尔金因代谢决定了M1 (氧化) 和M2 (聚胺) 的TAM表型.
研究的目的:
- 调查BH4 (四二丁) 的可用性是否会影响M1/M2-TAMs中的氨酸代谢.
- 确定补充BH4是否可以将M2-TAM重编程为M1-TAM.
- 评估塞帕特林 (SEP) 作为治疗HER2+乳腺癌的免疫疗法的潜力.
主要方法:
- 在M2类巨细胞中评估BH4水平.
- 在SEP治疗后分析阿尔金因代谢的转变.
- 评估巨细胞的抗原呈现能力和T细胞诱导.
- 评估HER2+癌细胞中的免疫细胞死亡.
主要成果:
- 塞皮阿丁 (SEP) 恢复了M2类巨细胞中的BH4水平.
- SEP将阿尔金因代谢转向氧化合成,将M2转化为M1 TAMs.
- 重编程的M1 TAM增强了抗原呈现和效应T细胞反应.
- 这导致HER2+癌细胞的免疫细胞死亡.
结论:
- 在TAM中,BH4的可用性对于指导阿尔金因代谢至关重要.
- 塞皮阿丁 (SEP) 通过恢复 BH4 水平,有效地将 M2 TAM 重编为 M1 TAM.
- 通过调节瘤微环境,SEP代表了对HER2+乳腺癌的一种有前途的新型免疫治疗策略.
更多相关视频
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

